Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of SMPDL3B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1083.85 | 328 / 328 | 86% | 12.49 | 153 / 178 |
thymus | 100% | 794.97 | 653 / 653 | 84% | 29.47 | 510 / 605 |
prostate | 80% | 151.53 | 196 / 245 | 95% | 21.91 | 477 / 502 |
lung | 88% | 372.35 | 511 / 578 | 78% | 27.84 | 900 / 1155 |
stomach | 76% | 593.44 | 272 / 359 | 90% | 19.74 | 256 / 286 |
kidney | 98% | 255.11 | 87 / 89 | 51% | 7.76 | 459 / 901 |
intestine | 52% | 505.00 | 503 / 966 | 94% | 22.05 | 496 / 527 |
breast | 58% | 163.52 | 267 / 459 | 87% | 15.22 | 976 / 1118 |
ovary | 3% | 2.64 | 6 / 180 | 99% | 38.75 | 424 / 430 |
bladder | 29% | 39.52 | 6 / 21 | 59% | 13.70 | 299 / 504 |
spleen | 83% | 107.27 | 200 / 241 | 0% | 0 | 0 / 0 |
uterus | 8% | 12.66 | 14 / 170 | 69% | 15.17 | 316 / 459 |
esophagus | 20% | 19.31 | 296 / 1445 | 52% | 9.59 | 96 / 183 |
tonsil | 0% | 0 | 0 / 0 | 64% | 8.85 | 29 / 45 |
peripheral blood | 45% | 48.13 | 416 / 929 | 0% | 0 | 0 / 0 |
skin | 30% | 30.85 | 550 / 1809 | 8% | 0.88 | 36 / 472 |
adipose | 28% | 44.56 | 339 / 1204 | 0% | 0 | 0 / 0 |
brain | 23% | 42.50 | 600 / 2642 | 1% | 0.04 | 4 / 705 |
liver | 4% | 3.92 | 10 / 226 | 9% | 0.89 | 36 / 406 |
heart | 4% | 3.86 | 33 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.39 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.17 | 2 / 80 |
blood vessel | 2% | 2.45 | 33 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.66 | 1 / 258 | 0% | 0.10 | 1 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006685 | Biological process | sphingomyelin catabolic process |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0006954 | Biological process | inflammatory response |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0008150 | Biological process | biological_process |
GO_0045087 | Biological process | innate immune response |
GO_0046466 | Biological process | membrane lipid catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0098552 | Cellular component | side of membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0004767 | Molecular function | sphingomyelin phosphodiesterase activity |
GO_0016798 | Molecular function | hydrolase activity, acting on glycosyl bonds |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
Gene name | SMPDL3B |
Protein name | Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-) Sphingomyelin phosphodiesterase acid like 3B |
Synonyms | ASMLPD ASML3B |
Description | FUNCTION: Lipid-modulating phosphodiesterase . Active on the surface of macrophages and dendritic cells and strongly influences macrophage lipid composition and membrane fluidity. Acts as a negative regulator of Toll-like receptor signaling (By similarity). Has in vitro phosphodiesterase activity, but the physiological substrate is unknown . Lacks activity with phosphocholine-containing lipids, but can cleave CDP-choline, and can release phosphate from ATP and ADP (in vitro) (By similarity). . |
Accessions | F8VXS3 ENST00000411604.5 Q92485 F8VWW8 Q5T0Y8 ENST00000373888.8 [Q92485-2] ENST00000373894.8 [Q92485-1] ENST00000549094.1 ENST00000548116.5 |